Dr. Pollyea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-777-1234Fax+1 303-493-7001- Is this information wrong?
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2007 - 2010
University of ChicagoResidency, Internal Medicine, 2003 - 2006
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2006 - Present
CO State Medical License 2011 - 2025
WY State Medical License 2021 - 2024
IL State Medical License 2003 - 2008
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia Start of enrollment: 2009 Dec 10
- Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML) Start of enrollment: 2009 Apr 01
- Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia Start of enrollment: 2012 Dec 06
- Join now to see all
Publications & Presentations
PubMed
- Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.Konopleva, M., Dail, M., Daver, N., Garcia, J., Jonas, B., Yee, K., Kelly, K., Vey, N., Assouline, S., Roboz, G., Paolini, S., Pollyea, D., Tafuri, A., Brandwein, J., ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Jan 18
- 1 citationsMulti-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving v...Minhajuddin, M., Stevens, B., Bosma, G., Abbott, D., Miltgen, N., Yuan, J., Treece, A., Jordan, C., Winters, A., Major, A., Siegele, B., Ewalt, M., Gutman, J., Pollyea...> ;Haematologica. 2023 Dec 14
- Progress and challenges in the acute leukemia field.Pollyea, D.> ;Best Practice & Research. Clinical Haematology. 2023 Dec 1
- Join now to see all
Journal Articles
- Randomized Comparison of Low Dose Cytarabine with or Without Glasdegib in Patients with Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeDaniel Pollyea, MD, Nature
- Venetoclax with Azacitidine Disrupts Energy Metabolism and Targets Leukemia Stem Cells in Patients with Acute Myeloid LeukemiaDaniel A Pollyea, Jonathan A Gutman, Enkhtsetseg Purev, Clayton Smith, Nature
- Venetoclax Combined with Decitabine or Azacitidine in Treatment-Naive, Elderly Patients with Acute Myeloid LeukemiaBrian A Jonas, Courtney D DiNardo, Olga Frankfurt, Daniel A Pollyea, Keith Pratz, Anthony Letai, Martha Arellano, Marina Konopleva, Hagop M Kantarjian, Blood
- Join now to see all
Abstracts/Posters
- Incidence of Serious Adverse Events, Pneumonitis, Infection and Sepsis in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphom...Daniel A Pollyea, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Outcomes Following Allogeneic Stem Cell Transplantation for AML in First Completion Remission Are Comparable between MRD Negative Patients and MRD Positive Patients Re...Daniel A Pollyea, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Phase 2 Study of Glasdegib for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with High Risk of Post-Allogeneic Stem Cell Transplantat...Daniel A Pollyea, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Data + Perspectives: Exploring the Role of Novel Agents and Emerging Strategies in the Management of Acute Myeloid Leukemia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Acute Myeloid Leukemia: Moving Beyond 7+360th American Society of Hematology Annual Meeting - 12/1/2018
- Join now to see all
Press Mentions
School of Medicine Honors Distinguished CliniciansMarch 29th, 2023
Therapeutic Advances in First-Line Management of Acute Myeloid LeukemiaNovember 5th, 2019
New Treatment at Colorado Cancer Center Is Possible Cure for AMLMarch 11th, 2019- Join now to see all
Hospital Affiliations
University of Colorado HospitalAurora, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
